Labshake search
Citations for Stemcell Technologies :
301 - 350 of 1716 citations for 4 4 Fluoro 2 hydroxyphenyl methyl 2 6 bis 1 methylethyl 5 propyl 3 pyridinemethanol since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2024Quote: ... Approximately 3 × 10^6 cells were placed in each well of an AggreWell 800 plate (STEMCELL Technologies # 34811) containing Stemflex medium enriched with 1X Revita supplement ...
-
Autophagy suppression in DNA damaged cells occurs through a newly identified p53-proteasome-LC3 axisbioRxiv - Cell Biology 2024Quote: ... organoids were removed from Matrigel and passaged with a split ratio of 1:4 using the protocol published by Stem Cell Technologies for use with their mouse IntestiCult system ...
-
bioRxiv - Bioengineering 2022Quote: ... and interleukin-3 (IL-3; 1 ng/mL, first day only; Stemcell Technologies; Canada). Cell density was maintained between 0.7-2×106 cells/mL by daily feeding with fresh expansion medium.
-
bioRxiv - Developmental Biology 2022Quote: ... Cells were passaged 1:6 using RELESR (StemCell Technologies 05872) for detachment of hESCs ...
-
bioRxiv - Immunology 2021Quote: ... (2) ImmunoCult™-XF T Cell Expansion Medium (STEMCELL Technologies) was supplemented with 1X Penicillin Streptomycin solution (ICM) ...
-
bioRxiv - Microbiology 2023Quote: ... and Heparin solution (2 μl/ml; Stem cell technologies #07980).
-
bioRxiv - Biophysics 2024Quote: ... ovaries were treated with collagenase (2 mg/mL; StemCell Technologies) and incubated in Modified Bath Saline (MBS ...
-
bioRxiv - Bioengineering 2024Quote: ... and 2 mg/mL dispase II (STEMCELL Technologies, Vancouver, Canada) for 4 hours under gentle agitation at 37° C ...
-
bioRxiv - Cell Biology 2023Quote: ... for EB formation in APEL-2 media (Stemcell Technologies, 5275) containing 10µM ROCK inhibitor ...
-
bioRxiv - Cell Biology 2023Quote: ... supplemented with 2 µM Thiazovivin (StemCell Technologies, Cambridge, MA 02142) and plated in a Matrigel-coated 12-well plate at a density of 3 x 105 cells per well ...
-
bioRxiv - Cancer Biology 2023Quote: ... heparin solution (final concentration, 2 µg/mL, STEMCELL Technologies, 07980), recombinant human EGF (20 ng/mL ...
-
bioRxiv - Neuroscience 2024Quote: ... in 2 ml EB Induction Medium (mTeSR+ (Stem Cell Technologies) + 20 ng/ml SCF (R & D Systems ...
-
bioRxiv - Neuroscience 2024Quote: ... supplemented with 2% NeuroCult™ SM1 neuronal supplement (STEMCELL Technologies) at a temperature of 37 °C and 5% CO2 ...
-
bioRxiv - Neuroscience 2024Quote: ... supplemented with 2% NeuroCultTM SM1 neuronal supplement (STEMCELL Technologies, 05711) and 2 mM GlutaMAX™ Supplement (Gibco ...
-
bioRxiv - Cell Biology 2024Quote: ... and 2× cell culture medium (MesencultTM ACF Plus (Stemcell Technologies) with 4 mM GlutaMAX-ITM (Gibco ...
-
bioRxiv - Molecular Biology 2023Quote: ... T cells were cultured at ∼1-2 x 106mL in ImmunoCult-XF T cell expansion medium (StemCell Technologies, Canada) supplemented with Penicillin-Streptomycin (Gibco ...
-
bioRxiv - Biophysics 2023Quote: ... and the media further supplemented with 30 U mL-1 of human recombinant IL-2 protein (STEMCELL Technologies, USA). T cells were incubated in a humidified incubator with 5% CO2 at 37°C and were split to 0.5×106 cells mL-1 when their concentration surpassed 2.5×106 cells per well or when medium became depleted (turning yellow in color) ...
-
bioRxiv - Cell Biology 2023Quote: Mature organoids are collected by rinsing the maintenance well using 1-2 ml cold DMEM/F12 (Stem Cell Technologies) + 15 mM HEPES + 1x GlutaMax (1:100 35050-038 ...
-
bioRxiv - Neuroscience 2023Quote: ... and cells were passaged 1-2 times per week using an enzyme-free reagent (ReLeSR; Stem Cell Technologies, 05872). Cells were checked for mycoplasma contamination every two weeks ...
-
bioRxiv - Bioengineering 2021Quote: Testicular organoids were made by mixing germ and somatic cells at a 1:4 ratio and placing them into AggreWell800™ microwells (STEMCELL Technologies, 34811) overnight ...
-
bioRxiv - Neuroscience 2021Quote: ... iPSCs were fed daily and split every 4-7 days using ReLeSR (StemCell Technologies) according to manufacturer’s instructions ...
-
bioRxiv - Cell Biology 2020Quote: ... were incubated overnight at 4° C with anti-CD3 (Clone UCHT1, StemCell Technologies, #60011) 10 μg/mL in PBS ...
-
bioRxiv - Developmental Biology 2023Quote: ... after which 4 ml maturation medium (Cerebral organoid kit, cat. n. 08570, StemCell Technologies) were gently added to each well ...
-
bioRxiv - Cell Biology 2022Quote: ... medium was replenished daily and were passaged every 5-6 days with Dispase I (StemCell Technologies, 07923) in small cell clumps ...
-
bioRxiv - Cell Biology 2024Quote: ... 1 ng/mL IL-3 (STEMCELL Technologies, 78040) and 1% Penicillin-Streptomycin (Gibco 15140122) ...
-
bioRxiv - Cell Biology 2020Quote: ... the iPSC were maintained in StemFlex medium and passaged 1-2 a week using ReLSR (STEMCELL Technologies, Vancouver, BC, Canada) dissociation buffer ...
-
bioRxiv - Bioengineering 2021Quote: ... All human iPSCs were cultured on Matrigel (Corning)-coated 6-well plates with mTeSR™1 medium (StemCell Technologies). Full-volume medium replacement with mTESR1 was performed daily ...
-
bioRxiv - Cancer Biology 2020Quote: ... Pellet is resuspended in 2-5ml accutase™ (StemCell Technologies, 07920), depending on the sample amount ...
-
bioRxiv - Developmental Biology 2022Quote: ... cells were collected with 2 mL mTeSRplus (Stem Cell Technologies, 05825), span down and resuspended in 1 mL mTeSRplus ...
-
bioRxiv - Cancer Biology 2020Quote: ... Pellet is resuspended in 2-5ml accutase™ (StemCell Technologies, 07920), depending on the sample amount ...
-
bioRxiv - Bioengineering 2021Quote: ... additionally supplemented with cytokines (Human Recombinant IL-2; Stemcell Technologies - #78036). To stimulate the cells ...
-
bioRxiv - Cancer Biology 2022Quote: ... PHA was washed and IL-2 (50 U/ml, StemCell Technology) was added to the medium and replaced every 2 days for a time period of 5 days.
-
A scalable, GMP-compatible, autologous organotypic cell therapy for Dystrophic Epidermolysis BullosabioRxiv - Bioengineering 2023Quote: ... 2% BSA (Miltenyi) and 10 uM ROCK inhibitor (StemCell technologies 72302). For all wash steps ...
-
bioRxiv - Immunology 2024Quote: ... and 50 IU/mL of IL-2 (STEMCELL Technologies, cat. 78220) at 1 million cells/mL ...
-
bioRxiv - Microbiology 2024Quote: ... then grown in presence of 100U/mL IL-2 (StemCell Technologies) for 4 days before being used in the various experiments ...
-
bioRxiv - Neuroscience 2024Quote: ... supplemented with 2% Neurocult SM1 Neuronal Supplement (StemCell Technologies; cat. #05711), 1% horse serum (Atlanta Biologicals ...
-
bioRxiv - Neuroscience 2024Quote: ... coated plates with 1.5-2 ml of mTeSR1 media (STEMCELL Technologies), media were changed daily except the day after passing ...
-
bioRxiv - Cell Biology 2024Quote: ... supplemented with or without 10 µM IWP-2 (STEMCELL Technologies, #72122) and 5% Matrigel matrix ...
-
bioRxiv - Cancer Biology 2024Quote: ... supplemented with 300IU/ml recombinant human IL-2 (Stemcell Technologies, 78036) for 14 days ...
-
bioRxiv - Neuroscience 2020Quote: ... Cells were passaged every 4 to 7 days with ReLeSR reagent (StemCell Technologies catalog #05872) to ensure that only undifferentiated stem cells remained in the cultures ...
-
bioRxiv - Genomics 2021Quote: ... and 4) one cord blood (CB001) collected with informed consent by StemCell Technologies (catalog #70007) (Table S1) ...
-
bioRxiv - Bioengineering 2023Quote: ... Cells were passaged every 4 days by non-enzymatic dissociation with ReLeSR (StemCell Technologies Inc.) and plated at a density of 5.0×105 per 60 mm plate.
-
bioRxiv - Cancer Biology 2024Quote: 200-500 edited residual HSCs were added to 4 mL of MethoCult H4435 (Stemcell Technologies) and differentiated for 14 days ...
-
bioRxiv - Bioengineering 2021Quote: ... microcapsules carrying HUES-8 cells were immersed in E8 medium for 1 h immediately after encapsulation and then transferred into E6 medium (without FGF-2 and TGF-β1, STEMCELL Technologies) for subsequent cultivation (2000 microcapsules per well) ...
-
bioRxiv - Cancer Biology 2022Quote: ... Tissues were cut into 1-2 mm pieces and subsequently incubated in serum-free medium containing collagenase/hyaluronidase (Stem Cell Technologies) at 37 ºC ...
-
bioRxiv - Cancer Biology 2023Quote: ... co-cultures were counted and recultured as 1 x 106 cells/ml in fresh medium containing 20 U/ml recombinant human IL-2 (StemCell Technologies) in the presence of soquelitinib or DMSO for additional 5 days ...
-
bioRxiv - Neuroscience 2024Quote: ... SH-SY5Y cells were counted and seeded at a density of 10.4 × 103 cells/cm2 in differentiation media (Neurobasal medium, 2% B27 supplement, 1% GlutaMAX, and 10 μM of all-trans retinoic acid [STEMCELL Technologies]). Differentiation media was replaced every other day until day 9 post-seeding ...
-
bioRxiv - Bioengineering 2023Quote: ... The PBMC pellet was resuspended in PBS supplemented with 2% FBS and 1 mM EDTA and monocyte isolation was performed using the EasySepTM human monocyte isolation kit (Stemcell Technologies) according to manufacturer instructions ...
-
bioRxiv - Cancer Biology 2024Quote: Tissue samples of ovarian tumours were cut into ∼1-2 mm3 pieces using sterile scalpels and digested with collagenase type IV (STEMCELL Technologies) for 2 hours at 37°C on a rotator ...
-
bioRxiv - Cell Biology 2021Quote: ... 1 μM PD03259010 and 3 μM CHIR99021 (STEMCELL Technologies) and 100 U/ml penicillin ...